Article info
PDFOriginal research
Acceptability of no-test medical abortion provided via telemedicine during Covid-19: analysis of patient-reported outcomes
- Correspondence to Jonathan Lord, Medical Director, MSI Reproductive Choices, London W1T 6LP, UK; jonathan.lord{at}msichoices.org.uk
Citation
Acceptability of no-test medical abortion provided via telemedicine during Covid-19: analysis of patient-reported outcomes
Publication history
- Received November 10, 2020
- Revised January 23, 2021
- Accepted January 31, 2021
- First published February 18, 2021.
Online issue publication
January 09, 2022
Article Versions
- Previous version (9 January 2022).
- Previous version (9 January 2022).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage